XML 28 R17.htm IDEA: XBRL DOCUMENT v3.21.2

Incentive Stock Programs

6 Months Ended

Jun. 30, 2021

Incentive Stock Programs

Incentive Stock Programs

Note 8 — Incentive Stock Programs

​

In the first six months of 2021, Abbott granted 2,730,398 stock options, 478,490 restricted stock awards and 4,624,439 restricted stock units under its incentive stock program.  At June 30, 2021, approximately 101 million shares were reserved for future grants.  Information regarding the number of options outstanding and exercisable at June 30, 2021 is as follows:

​

​	​	​	​	​	​	​
​		Outstanding			Exercisable
Number of shares			30,091,814	​		23,273,096
Weighted average remaining life (years)			6.0	​		5.2
Weighted average exercise price		$	62.45	​	$	51.56
Aggregate intrinsic value (in millions)		$	1,631	​	$	1,498

​

The total unrecognized share-based compensation cost at June 30, 2021 amounted to approximately $645 million which is expected to be recognized over the next three years.

X

- Definition

The entire disclosure for share-based payment arrangement.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-URI http://asc.fasb.org/topic&trid=2228938

+ Details

Name:	us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock
Namespace Prefix:	us-gaap_
Data Type:	nonnum:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- References

No definition available.

+ Details

Name:	us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration